top of page
Introducing Our End-to-End Platform
PetaPoly™ 4.0
PetaPoly™ 4.0 is a cutting-edge AI platform transforming therapy discovery and repurposing in life sciences. By leveraging polypharmacology and petabyte-scale data, it accelerates molecular evaluations, reduces trial costs, and ensures safety through extensive toxicity and efficacy simulations. Empowering innovation and precision, PetaPoly™ 4.0 pioneers effective therapeutic solutions, improving patient outcomes and advancing transformative wellness in the biotech industry.
1.
Disease-Signalomic pathways Investigation
2.
Network based Combination therapy analysis
3.
AI generative and/or multi-target driven chemogenomic selection of hits compound
and prediction of Toxicity/ Phototoxicity/ ADME / PK/PD using machine learning technology
4.
Molecular docking, protein modeling and molecular dynamics of hit compounds and target protein relationship
5.
AI Retro-affinity analysis (Multi-dock) of hit compound and novel protein interaction
6.
AI Prediction of the successfulness of clinical trials
7.
Prediction of chemical synthesis of hit ligands using AI retrosynthesis
8.
The optimal solution of hit compounds for in vitro / in vivo pharmacology investigation
bottom of page